HRTX
Heron Therapeutics, Inc. (HRTX) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
R&D intensity of 8.1% of revenue suggests a relatively contained direct environmental footprint versus larger manufacturing-heavy peers, though disclosure is limited.
The company’s asset-light profile likely reduces energy, water, and waste exposure compared with peers that operate more capital-intensive production networks.
No provided metrics indicate superior emissions management or climate-transition governance, leaving environmental positioning broadly average versus peers.
Limited environmental disclosure in the supplied data constrains evidence of stronger sustainability controls relative to better-reporting peers.
Social
Stock-based compensation at 7.4% of revenue indicates meaningful employee alignment, but it also suggests dilution pressure that is less favorable than peers with lower equity reliance.
Moderate R&D spending supports retention of specialized talent and product development capability, which is generally constructive versus peers with weaker innovation investment.
The available data do not show workforce safety, diversity, or product-access metrics, so social positioning cannot be assessed as stronger than peers.
Overall social performance appears mixed because compensation structure and talent investment are supportive, yet peer-relative disclosure remains incomplete.
Governance
Debt-to-equity of 21.5x indicates a highly leveraged capital structure, which raises governance sensitivity around balance-sheet discipline versus less levered peers.
Negative net debt to EBITDA suggests net cash generation support, but the extreme debt-to-equity ratio still points to a weaker governance profile than peers.
Stock-based compensation at 7.4% of revenue implies material equity dilution, which can weaken capital-allocation discipline relative to peers with tighter compensation control.
The supplied metrics do not include board independence, audit quality, or shareholder-rights data, limiting evidence of governance strength versus peers.
Overall Score
HRTX appears broadly average on ESG relative to peers, with modestly supportive social and environmental characteristics offset by weaker governance signals from leverage and dilution.
Score Driver: High Leverage And Equity Dilution Are The Most Material Peer-Relative Governance Constraints.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Heron Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
